Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
rare diseases
Biotech
Pfizer puts assets up for sale in early-stage rare disease pivot
Pfizeris “exploring externalization opportunities for a number of highly innovative, niche programs” as part of a rare disease R&D rethink.
Nick Paul Taylor
Jan 6, 2023 7:30am
Takeda takes orphan drug to regulators after seeing phase 3 data
Jan 5, 2023 9:35am
Medable, Every Cure team up to repurpose drugs for rare diseases
Jan 4, 2023 3:20pm
Ipsen's rare disease candidate rejected after mounting delays
Dec 27, 2022 10:44am
AstraZeneca's Alexion hopes to extend dominance in PNH
Dec 16, 2022 7:25am
Novartis touts new budding disease med as it battles AstraZeneca
Dec 13, 2022 10:00am
